<h1>Dolphin Medical Services Announces Board Meeting to Review Q1 2026-27 Financial Results</h1>
Dolphin Medical Services Ltd has scheduled a meeting of its Board of Directors to consider and approve the Unaudited Standalone Financial Results for the first quarter of the financial year 2026-27.
The company’s board is set to convene on Friday, August 14, 2026, with the purpose of reviewing the results for the period ended June 30, 2026.
In addition to the board meeting announcement, the company provided an update regarding its insider trading regulations. The trading window for the securities of Dolphin Medical Services Ltd for all Designated Persons, including Insiders, was closed effective from July 01, 2026. This restriction will remain in place until 48 hours following the publication of the financial results.
Stock Price Movement
Dolphin Medical Services Ltd. shares settled on Monday at ₹7.14, falling 4.55% from previous close. The stock experienced intraday volatility, moving across a range bounded by a low of ₹7.12 and a high of ₹7.85.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.